Safety of Cabergoline in the Management of Pituitary Prolactin-Induced Symptoms with Patients Treated with Atypical Neuroleptics
Publisher： Bentham Science Publishers
E-ISSN： 2212-3911|7|2|92-98
ISSN： 1574-8863
Source： Current Drug Safety, Vol.7, Iss.2, 2012-04, pp. : 92-98
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
